Page last updated: 2024-09-03

gyki 53655 and irampanel

gyki 53655 has been researched along with irampanel in 1 studies

Compound Research Comparison

Studies (gyki 53655)	Trials (gyki 53655)	Recent Studies (post-2010) (gyki 53655)	Studies (irampanel)	Trials (irampanel)	Recent Studies (post-2010) (irampanel)
111	0	22	8	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akiba, I; Barsoumian, E; Brenner, M; Iizuka, M; Nishimura, S; Palluk, R; Steinhäuser, C; Weiser, T; Wienrich, M; Zhou, M	1

Other Studies

1 other study(ies) available for gyki 53655 and irampanel

Article	Year
Characterization of the anticonvulsant and neuroprotectant BIIR 561 CL in vitro: effects on native and recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 362, Issue:4-5 Topics: Animals; Anticonvulsants; Benzodiazepines; Cells, Cultured; Dose-Response Relationship, Drug; Female; Glutamic Acid; Humans; Hydrogen-Ion Concentration; Neuroprotective Agents; Oxadiazoles; Rats; Receptors, AMPA; Recombinant Proteins	2000

Article

Year

Characterization of the anticonvulsant and neuroprotectant BIIR 561 CL in vitro: effects on native and recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.

Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 362, Issue:4-5

Topics: Animals; Anticonvulsants; Benzodiazepines; Cells, Cultured; Dose-Response Relationship, Drug; Female; Glutamic Acid; Humans; Hydrogen-Ion Concentration; Neuroprotective Agents; Oxadiazoles; Rats; Receptors, AMPA; Recombinant Proteins

2000